the High variability is not typical for COVID-19, however, currently difficult to assess the impact of several tens of past mutations on the ability to affect the human body and cause severe or not severe disease.
told About it in conversation with RIA Novosti the head of Rospotrebnadzor Anna Popova. However, she stressed that now “exactly” it is known that the coronavirus is a new-type high variability is not.
“It is impossible to compare today with the flu virus. Another thing is that even the few tens of mutations, which are now described, and it is normal for any organism, it is impossible to assess in terms of impact on the change of this virus to infect humans, causing serious or not serious illness”, – quotes Agency the words of the interlocutor.
According to her, now all States share the results of their research in different information systems. Their study allows to conclude that high levels of mutations COVID-19 does not show.
she Also said who will start vaccination against coronavirus is a new type.
According to Popova, a large number of vaccines from COVID-19 from to make will be difficult. At present, however, at the state level the issue of increase in production capacity for these purposes.
“According to the General rules, first vaccinated at risk. If you have a chance, and today she worked out at the state level, we will be able to develop a vaccine for most of the population of Russia”, – said the head of Rospotrebnadzor.
